We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
Analysis of Sam Altman's investments in Retro Biosciences, GPT-4b micro AI model, and cellular reprogramming. Real prospects, risks, and competitors. Read details.
